2012;7(6):e38760
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Alzheimers Disease And Cognitive Decline Glutathione has not yet been tested intranasally in people with Alzheimers disease (AD), but observational data show: Lower glutathione levels in the hippocampus and frontal cortex of people with AD and mild cognitive impairment An association between lower brain glutathione and higher amyloid plaque burden in older adults People carrying the ApoE4 gene variant , a major genetic risk factor for AD, appear to have: Higher oxidative stress in brain tissue Lower levels of reduced glutathione compared to non-carriers These findings support the idea that glutathione is closely tied to brain aging and degeneration, though we still lack clinical trials testing intranasal glutathione in AD or ApoE4 carriers
Evidence-Base Disclosure The published evidence base for AOD-9604 consists predominantly of preclinical research animal models (often rats or mice) and in vitro cell-culture experiments
For exercise performance and VO2 max improvement, the evidence from human exercise studies suggests that MOTS-c's acute rise following high-intensity training is part of the adaptive signal driving mitochondrial biogenesis and cardiovascular remodeling
With regenerative medicine, you can move beyond temporary relief and activate your bodys natural healing powerrestoring mobility, reducing pain, and reclaiming your confidence